Norgalax (Docusate Sodium)

Docusate Sodium, the active ingredient in Norgalax, is a surfactant laxative presented as a rectal preparation for rectal use. It softens hard, dry stools and relieves constipation in adults.

GNH USA supplies Norgalax as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norgalax (docusate sodium) is used as a stool softener within the laxative therapeutic class.

- Constipation: softens stool and facilitates easier passage. - Hard, dry stools: increases stool moisture content to prevent straining. - Prevention of straining during bowel movements: reduces effort required for evacuation.

Docusate sodium is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Abdominal cramping: mild discomfort in the lower abdomen. - Rectal irritation: burning or itching at the site of administration. - Nausea: feeling of unease or urge to vomit. - Flatulence: increased gas production. - Mild diarrhea: loose stools occurring occasionally. - Throat irritation: sensation of dryness when using suppository form.

Serious or Rare Side Effects: - Allergic reaction: rash, hives, or swelling requiring medical attention. - Severe abdominal pain: intense pain that does not resolve. - Rectal bleeding: presence of blood in stool or on the suppository. - Electrolyte imbalance: rare disturbances in sodium or potassium levels.

Before using Norgalax, consider the following safety measures.

- Pregnancy: safety not established; consult a healthcare professional. - Breastfeeding: unknown effects; use with caution. - Existing gastrointestinal disease: avoid if intestinal obstruction or severe inflammatory bowel disease is present. - Use with other laxatives: may increase risk of electrolyte disturbances. - Age: use cautiously in elderly patients. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Docusate sodium may interact with other medications; monitor as indicated.

Major Interactions (Avoid): - Anticholinergic agents: may reduce the stool‑softening effect. - Mineral oil: can interfere with absorption of other oral drugs. - Stimulant laxatives: combined use may increase risk of dehydration.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolyte levels during concurrent use. - Warfarin: potential alteration of vitamin K absorption may affect anticoagulation control.